← All Sponsors
SPONSOR

D3 Bio (Wuxi) Co., Ltd

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: KRAS P.G12C
NCT05410145 Phase 1, Phase 2
Recruiting

A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

KRAS P.G12C
United States, Australia, China View Trial →